Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women

Obstetrics and Gynecology

Volumn 121, Issue 4, 2013, Pages 891-896

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

DRUG TREATMENT FAILURE; FEMALE FERTILITY; HORMONAL THERAPY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MEDICATION THERAPY MANAGEMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; UTERUS BLEEDING; ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; FEMALE; MIDDLE AGED;

ACUTE DISEASE; ADOLESCENT; ADULT; FEMALE; HUMANS; MIDDLE AGED; UTERINE HEMORRHAGE; YOUNG ADULT;

EID: 84876213253     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000428646.67925.9a     Document Type: Review

References (20)

1. Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. FIGO Working Group on Menstrual Disorders. Int J Gynaecol Obstet 2011; 113: 3-13.
2. Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012; 120: 197-206.
3. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004; 111: 734-40.
4. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
5. Von Willebrand disease in women. ACOG Committee Opinion No. 451. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009; 114: 1439-43.
6. National Collaborating Centre for Women's and Children's Health, National Institute of Clinical Excellence. Heavy menstrual bleeding. Clinical guideline. London: RCOG Press; 2007. Available at: http://www.nice.org.uk/nicemedia/live/ 11002/30401/30401.pdf. Retrieved December 5, 2012.
7. DeVore GR, Owens O, Kase N. Use of intravenous Pre-marin in the treatment of dysfunctional uterine bleeding - a double-blind randomized control study. Obstet Gynecol 1982; 59: 285-91.
8. Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol 2006; 108: 924-9.
9. U. S. Medical Eligibility Criteria for Contraceptive Use, 2010. Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep 2010; 59(RR-4): 1-86.
10. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2011; 60: 878-83.
11. Food and Drug Administration. FDA online label repository. Available at: http://labels.fda.gov. Retrieved December 5, 2012.
12. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD000249. DOI: 10.1002/14651858.CD000249.
13. Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010; 116: 865-75.
14. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011; 93: 1577-85.
15. James AH, Kouides PA, Abdul-Kadir R, Dietrich JE, Edlund M, Federici AB, et al. Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. Eur J Obstet Gynecol Reprod Biol 2011; 158: 124-34.
16. Hamani Y, Ben-Shachar I, Kalish Y, Porat S. Intrauterine balloon tamponade as a treatment for immune thrombocytopenic purpura-induced severe uterine bleeding. Fertil Steril 2010; 94: 2769.e13-2769.e15.
17. Kadir RA, Lukes AS, Kouides PA, Fernandez H, Goudemand J. Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril 2005; 84: 1352-9.
18. Bettocchi S, Ceci O, Vicino M, Marello F, Impedovo L, Selvaggi L. Diagnostic inadequacy of dilatation and curettage. Fertil Steril 2001; 75: 803-5.
19. Nichols CM, Gill EJ. Thermal balloon endometrial ablation for management of acute uterine hemorrhage. Obstet Gynecol 2002; 100: 1092-4.
20. Bowkley CW, Dubel GJ, Haas RA, Soares GM, Ahn SH. Uterine artery embolization for control of life-threatening hemorrhage at menarche: brief report. J Vasc Interv Radiol 2007; 18: 127-31.